Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alzamend Neuro Inc
Market Cap
$5.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.99M
Operating Margin
-3317.65%
TTM Avg
-1658.83%
3Y Avg
-2341.84%
5Y Avg
-1561.23%
Market Cap
$4.96M
Operating Margin
-19.28%
TTM Avg
1.28%
3Y Avg
11.60%
5Y Avg
11.60%
Market Cap
$4.79M
Operating Margin
-1128.11%
TTM Avg
-14522.19%
3Y Avg
-8776.16%
5Y Avg
-5850.77%
Market Cap
$6.03M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$6.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -3317.65% | -1658.83% | -2341.84% | -1561.23% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | -19.28% | 1.28% | 11.60% | 11.60% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -1128.11% | -14522.19% | -8776.16% | -5850.77% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | -330.12% |
| 2017-01-31 | -330.12% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
